{"result": "(\"entity\"<|>FALLO INTESTINAL<|>EVENT<|>Intestinal failure is a condition that can lead to complications such as bacterial overgrowth and liver disease due to inadequate nutrient absorption.)\n##\n(\"entity\"<|>HIPOMOTILIDAD INTESTINAL<|>EVENT<|>Hypomotility of the intestine is a condition that can contribute to intestinal failure and bacterial overgrowth.)\n##\n(\"entity\"<|>ENDOTOXINAS<|>PERSON<|>Endotoxins are toxins released from bacteria that can enter the portal circulation and affect liver function in patients with intestinal failure.)\n##\n(\"entity\"<|>COLECISTOQUININA<|>PERSON<|>Cholecystokinin is a hormone that stimulates bile flow and is affected by enteral stimulation.)\n##\n(\"entity\"<|>SECRETINA<|>PERSON<|>Secretin is a hormone that regulates water homeostasis and is involved in the digestive process, influenced by nutrient intake.)\n##\n(\"entity\"<|>GASTRINA<|>PERSON<|>Gastrin is a hormone that stimulates gastric acid secretion and is affected by the presence of food in the stomach.)\n##\n(\"entity\"<|>MOTILINA<|>PERSON<|>Motilin is a hormone that stimulates gastrointestinal motility and is influenced by enteral feeding.)\n##\n(\"entity\"<|>POLIPÉPTIDO PANCREÁTICO<|>PERSON<|>Pancreatic polypeptide is a hormone that regulates pancreatic secretions and is affected by nutrient intake.)\n##\n(\"entity\"<|>GLUCAGÓN<|>PERSON<|>Glucagon is a hormone that raises blood glucose levels and is involved in the metabolic response to nutrient intake.)\n##\n(\"relationship\"<|>FALLO INTESTINAL<|>HIPOMOTILIDAD INTESTINAL<|>Hypomotility of the intestine can lead to intestinal failure due to inadequate nutrient absorption<|>7)\n##\n(\"relationship\"<|>FALLO INTESTINAL<|>ENDOTOXINAS<|>Endotoxins released into the portal circulation can exacerbate complications in patients with intestinal failure<|>6)\n##\n(\"relationship\"<|>HIPOMOTILIDAD INTESTINAL<|>ENDOTOXINAS<|>Hypomotility can lead to bacterial overgrowth, resulting in the release of endotoxins<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>COLECISTOQUININA<|>Parenteral nutrition can lead to decreased stimulation of cholecystokinin, affecting bile flow<|>4)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>SECRETINA<|>Parenteral nutrition can reduce the secretion of secretin, impacting digestive processes<|>4)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>GASTRINA<|>Parenteral nutrition can lead to decreased gastrin levels, affecting gastric acid secretion<|>4)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>MOTILINA<|>Parenteral nutrition can reduce motilin levels, leading to decreased gastrointestinal motility<|>4)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>POLIPÉPTIDO PANCREÁTICO<|>Parenteral nutrition can affect pancreatic polypeptide levels, influencing pancreatic secretions<|>4)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>GLUCAGÓN<|>Parenteral nutrition can alter glucagon levels, impacting blood glucose regulation<|>4)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: la función de la membrana del ca-\nnalículo biliar y reducir el flujo biliar69.\n\n- Sobrecrecimiento bacteriano: El sobrecreci-\nmiento bacteriano es relativamente frecuente\nen pacientes con fallo intestinal por hipomotili-\ndad intestinal con liberación de endotoxinas a\nla circulación portal, las cuales pueden afectar a\nlos hepatocitos72.\n\n• Causas dependientes del tipo de soporte nu-\ntricional:\n\n- La administración de exceso de calorías es uno\nde los principales factores que contribuyen a\nesteatosis y colestasis. Un exceso de carbohi-\ndratos produce hiperinsulinemia, estimula la\nlipogénesis e inhibe la beta-oxidación de los\nácidos grasos. Además, se ha establecido una\ncorrelación entre el aporte de >1 g/kg/día de\nTCL y el desarrollo de colestasis y afectación\nhepática73.\n\n- Tipo de emulsión lipídica: Las emulsiones lipídi-\ncas clásicas, basadas en el aceite de soja con un\naporte elevado de ácidos grasos W6, pueden\npredisponer a un aumento de la producción de\nmetabolitos proinflamatorios derivados de los\nácidos grasos e inducir un menor aclaramiento\nhepático (esteatosis hepática) de los lípidos in-\nfundidos. Los esteroles vegetales (fitosteroles)\npresentes en las EL, se han relacionado con al-\nteraciones de la función hepática39.\n\n- Reposo digestivo (ausencia de estímulo ente-\nral): La deprivación de nutrientes en la luz dis-\nminuye la circulación enterohepática de ácidos\nbiliares y disminuye la producción de hormonas\nGI que se estimulan habitualmente con la in-\ngesta oral (colecistoquinina, secretina, gastrina,\nmotilina, polipéptido pancreático y glucagón)74:\n\n  - Estas hormonas son estimulantes del flujo bi-\n    liar, por tanto, ante una ausencia de estímulo\n    enteral existe una disminución de la motilidad\n    intestinal y de la contracción intestinal.\n  - Las asas intestinales, muchas veces dilatadas y\n    atónicas, son más susceptibles de ser coloni-\n    zadas por bacterias y producirse el fenómeno\n    del sobrecrecimiento bacteriano.\n\n- Déficits nutricionales: El déficit de ácidos grasos\nesenciales y el de proteínas se han relacionado\ncon esteatosis.\n\n- Infusión continua de la NP: El aporte continuo\nde la NP puede predisponer a un estado de hiper-\n---\n774     BLOQUE: SOPORTE NUTRICIONAL AVANZADO\n\ninsulinismo que favorece el acúmulo graso en el hígado. La perfusión cíclica comparada con la infusión continua durante las 24 horas ha demostrado que contribuye a disminuir las concentraciones séricas de las enzimas hepáticas y de bilirrubina conjugada75.\n\n- Manejo de la enfermedad hepática asociada a la nutrición parenteral:\n\nLa monitorización cuidadosa de los test funcionales hepáticos ayuda a identificar el problema de modo precoz, con el fin de aplicar lo antes posible las estrategias recomendadas:\n\n- Aporte de nutrientes vía enteral: Va a permitir reducir el aporte calórico de la NP y puede ayudar a disminuir el desarrollo de las CHB. El aporte enteral disminuye la atrofia intestinal y la pérdida de inmunidad de la mucosa intestinal, evitando el disbalance de la microbiota que promueve la endotoxemia y el daño hepático76. El uso del tracto intestinal, requiere que este sea útil. En pacientes con regímenes de NP prolongados se puede valorar el uso de técnicas de alargamiento intestinal (como la fistuloclisis) que han demostrado disminuir e incluso evitar la utilización de NP en pacientes seleccionados77, así como el uso de fármacos, como los análogos de GLP-2 (teduglutide), que han demostrado un aumento de la superficie intestinal absortiva, asociado a una menor dependencia de la NP en pacientes con insuficiencia intestinal78.\n- Ajustes de la nutrición parenteral: Es importante ajustar el aporte de nutrientes de la NP, para evitar la sobrealimentación, reduciendo la cantidad de glucosa (< 5 g/kg/día) y de TCL en la EL (< 1 g/kg/día). En los pacientes con regímenes de NP prolongados, se debe valorar el aporte de EL enriquecidas en AGW3, ya que los estudios en ese tipo de paciente reflejan una eficacia en la prevención y reversión de la enfermedad hepática asociada a la NP79-81.\n- Tratamiento del sobrecrecimiento bacteriano: Tratamiento empírico con metronidazol, dirigido a las bacterias anaerobias de la flora colónica.\n- Trat\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>SOPORTE NUTRICIONAL AVANZADO<|>ORGANIZATION<|>SOPORTE NUTRICIONAL AVANZADO refers to advanced nutritional support strategies for patients, particularly those with liver disease and intestinal failure.)\n##\n(\"entity\"<|>HÍGADO<|>GEO<|>The liver is an organ that can be affected by various nutritional factors, leading to conditions such as steatosis and cholestasis.)\n##\n(\"entity\"<|>ACIDOS GRASOS ESENCIALES<|>PERSON<|>Essential fatty acids are crucial nutrients that, when deficient, can lead to liver conditions like steatosis.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Parenteral nutrition (NP) is a method of feeding that bypasses the gastrointestinal tract, often used in patients with intestinal failure.)\n##\n(\"entity\"<|>METRONIDAZOL<|>PERSON<|>Metronidazole is an antibiotic used to treat bacterial overgrowth, particularly targeting anaerobic bacteria in the colon.)\n##\n(\"entity\"<|>GLP-2<|>PERSON<|>GLP-2 (glucagon-like peptide-2) is a hormone that can enhance intestinal absorption and reduce dependence on parenteral nutrition in patients with intestinal insufficiency.)\n##\n(\"relationship\"<|>SOPORTE NUTRICIONAL AVANZADO<|>NUTRICIÓN PARENTERAL<|>SOPORTE NUTRICIONAL AVANZADO involves strategies to manage and optimize parenteral nutrition in patients with liver disease<|>8)\n##\n(\"relationship\"<|>HÍGADO<|>NUTRICIÓN PARENTERAL<|>The liver can be adversely affected by parenteral nutrition, leading to conditions like steatosis and cholestasis<|>7)\n##\n(\"relationship\"<|>ACIDOS GRASOS ESENCIALES<|>HÍGADO<|>Deficiency of essential fatty acids can lead to liver conditions such as steatosis<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>METRONIDAZOL<|>Metronidazole is used to treat bacterial overgrowth that can occur in patients receiving parenteral nutrition<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>GLP-2<|>GLP-2 can help reduce the dependency on parenteral nutrition by enhancing intestinal absorption<|>6)\n<|COMPLETE|>"}]}